Zhang H, et al. Novel influenza polymerase PB2 inhibitors for the treatment of influenza A infection. Bioorg Med Chem Lett. 2019 Aug 24:126639.
Exploration of the chemical space of known influenza polymerase PB2 inhibitor Pimodivir, was performed by our group. We synthesized and identified compounds 16a and 16b, two novel thienopyrimidine derivatives displaying anti-influenza A activity in the single digit nanomolar range in cell culture. Binding of these unique compounds in the influenza polymerase PB2 pocket was also determined using molecular modeling.
See Also:
Latest articles in those days:
- [preprint]Egyptian rousette bat humoral immunity to H9 influenza hemagglutinin 7 hours ago
- The surveillance programme for avian influenza (AI) in Norwegian wildlife 2025 18 hours ago
- The surveillance programme for avian influenza (AI) in poultry in Norway 2025 18 hours ago
- Pathological evidence of neurotropism and oculotropism in wild black-headed gulls naturally infected with H5N1 high pathogenicity avian influenza 19 hours ago
- Birth cohort effects in adults associated with influenza A(H1N1)pdm09 vaccine effectiveness 1 days ago
[Go Top] [Close Window]


